Giant-cell tumours of the spine

J Bone Joint Surg Br. 1993 Jan;75(1):148-54. doi: 10.1302/0301-620X.75B1.8421014.

Abstract

Between 1955 and 1989 we treated 24 patients (17 women and seven men) with giant-cell tumours of the spine at the Mayo Clinic. Their mean age was 30 years and the mean follow-up time was 12.4 years. Pain was the presenting symptom in all and half had a neurological deficit. The cervical, thoracic, and lumbar spines were equally involved. The tumours recurred in five of the 14 patients treated by one-stage surgery and in five of the ten treated by two-stage surgery. Seven patients received adjuvant radiotherapy, one for the primary lesion and six for recurrent lesions. Surgical management was by curettage or en bloc excision depending on the location and the extent of the tumour. Because of the risk of sarcomatous transformation, radiation therapy should be reserved for patients with incomplete excision or for those with local recurrence.

MeSH terms

  • Adolescent
  • Adult
  • Combined Modality Therapy
  • Female
  • Giant Cell Tumors / diagnostic imaging*
  • Giant Cell Tumors / radiotherapy
  • Giant Cell Tumors / surgery
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Radiography
  • Spinal Fusion
  • Spinal Neoplasms / diagnostic imaging*
  • Spinal Neoplasms / radiotherapy
  • Spinal Neoplasms / surgery